Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1392-3; author reply 1394-5. doi: 10.1007/s00259-008-0759-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / radiotherapy*
  • Bone Neoplasms / secondary
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / radiotherapy
  • Combined Modality Therapy
  • Diphosphonates / therapeutic use*
  • Etidronic Acid / therapeutic use*
  • Female
  • Humans
  • Male
  • Organometallic Compounds / therapeutic use*
  • Organophosphorus Compounds / therapeutic use
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / radiotherapy
  • Radioisotopes / therapeutic use
  • Radiopharmaceuticals / therapeutic use
  • Rhenium / therapeutic use

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Organometallic Compounds
  • Organophosphorus Compounds
  • Radioisotopes
  • Radiopharmaceuticals
  • rhenium-186 HEDP
  • Rhenium
  • samarium Sm-153 lexidronam
  • Etidronic Acid